- Home page | CEPI
CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats
- About CEPI | CEPI
CEPI was launched after the global response to the 2014-2016 West Africa Ebola epidemic fell tragically short and there was a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics
- Careers | CEPI
We foster a learning-centred work culture Our development approach is to enable everyone at CEPI to get better every day The nature of our work also enables us to learn through stimulating experiences and by engaging with global health stakeholders
- CEPI 2. 0 and the 100 Days Mission
CEPI’s 2022-2026 strategy, known as CEPI 2 0, is helping to Prepare, Transform, and Connect the world so that it can respond to the next Disease X by accelerating the development of safe, effective, globally accessible vaccines in as little as 100 days
- Calls for Proposals - CEPI
We’ll also provide you with some guidance and recommendations on your project and a potential application to one or more of CEPI’s Calls We are particularly interested in hearing from vaccine developers and researchers in the Global South
- Our portfolio - CEPI
Our interactive portfolio provides information on each of the vaccine candidates that CEPI has invested in as well as our Centralised Lab Network, Preclinical Models and Vaccine Manufacturing Network partners
- Documents library - CEPI
Find key documents and resources related to CEPI's activities, policies and governance below
- COVID-19 - CEPI
In the months that followed, CEPI built one of the world’s largest and most diverse COVID-19 vaccine portfolios, based on the principles of speed, scale, and access CEPI invested over US $1 5 billion to advance 14 COVID-19 vaccines, seven of which have been approved for domestic or global use
|